Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 26, 2018

Study Completion Date

October 26, 2018

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

TACE

Control arm will be treated by 2 or 3 cures of TACE DC beads at week 0, 8 and 16 (if required)

OTHER

TACE+ RTC

Experimental group will be treated by one cure of TACE DC Beads at week 0 then, within two weeks, by external conformational radiotherapy in 18 sessions

Trial Locations (18)

Unknown

CHU Amiens, Amiens

CHU d'Angers, Angers

CH Avignon, Avignon

Institut Sainte Catherine, Avignon

CHU de Bordeaux, Bordeaux

AP-HP Henri Mondor, Créteil

CHU Dijon, Dijon

CHD les Oudairies, La Roche-sur-Yon

CHR de Lille Hôpital Claude Huriez, Lille

CHU de Lyon, Lyon

CHU de Nancy Hôpital Brabois, Nancy

CHU Nantes, Nantes

CHR Orléans, Orléans

AP-HP Paul Brousse Villejuif, Paris

Hôpital Tenon, Paris

La Pitié-Salpétrière, Paris

CHU de Reims, Reims

Centre Eugene Marquis, Rennes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01300143 - Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter